ASLAN Pharmaceuticals Presents New Data From Phase 2b Study

ASLAN Pharmaceuticals Presents New Data From Phase 2b Study of Eblasakimab in Atopic Dermatitis in Late Breaker Presentation at 32nd European Academy of Dermatology and Venereology Congress

ASLAN Pharmaceuticals Presents New Data From Phase 2b Study of Eblasakimab in Atopic Dermatitis in Late Breaker Presentation at 32nd European Academy of Dermatology and Venereology Congress

itbusinessnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from itbusinessnet.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

Singapore , California , United States , Oregon , Francesj Storrs , Ashleyr Robinson , Alex Kaoukhov , Ericl Simpson , Emma Thompson , Pharmaceuticals Nasdaq , Linkedin , Spurwing Communications , Venereology Congress , Science University , European Academy Of Dermatology , Lifesci Advisors , Oregon Health , European Academy , Medical Dermatology , Lead Investigator , Eczema Area , Severity Index , Chief Medical Officer , Investigator Global Assessment , Atopic Dermatitis , San Mateo , Sci Advisors ,